12 September 2024NewsCareersMuireann Bolger

WBD to merge with firm to create ‘powerhouse’ practice

Deal marks the third major M&A to be announced so far this month | Combined firms have a total gross revenue of more than $742 million | Business marriage seen as “natural fit and clear win-win”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

HLK adds CRISPR specialist as partner

10 September 2024 CRISPR expert with two decades of experience in biotechnology and life sciences, joins HLK as a partner | Latest addition previously held leadership roles at Murgitroyd and HGF | Partner will be attending LSPN North America Fall 2024 in San Francisco.

Careers

Brown Rudnick expands with new partner duo

5 September 2024 Firm adds pair to its Washington DC office | Both bring experience in patent counselling and IP transactions | Expertise in biotech, life sciences, pharmaceutical sectors, consumer products, biomedical, chemical, food science, agriculture, and medical devices.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

WBD to merge with firm to create ‘powerhouse’ practice

More on this story

Editor's picks

Editor's picks

More features